Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

New product for cancer heading for clinical testing at ProMetic

Sep. 25, 2002

Novel VEGFR inhibitors prepared and tested at Taisho

Sep. 25, 2002

GSK designs new series of antiangiogenic agents

Sep. 23, 2002

Hybridon and Aegera collaborate to develop antisense drug targeting XIAP gene

Sep. 23, 2002

Access Oncology obtains rights to develop and market antitumor alkylphosphocholine

Sep. 23, 2002

New data on the antiangiogenic effects of endostatin against advanced solid tumors

Sep. 23, 2002

Favorable pharmacokinetic profile described for new camptothecin analogue DRF-1042

Sep. 23, 2002

Pfizer returns rights to Onyx products

Sep. 20, 2002

Copper chelator exerts antiangiogenic effects via suppression of NF-kB activity

Sep. 20, 2002

AP-23675 discovered for primary bone cancers and bone metastases

Sep. 20, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 29, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 29, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...